Institutional Ownership Pharma Cyte Biotech, Inc. (PMCB)
This table provides information about the institutional ownership of Pharma Cyte Biotech, Inc. (PMCB). We have compiled data on the 31 institutions that hold shares in the stock, with a total of 1.12 Million shares, which have been reported (via 13F filing form) to have a value of $1.99 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Sachetta, LLC
Lynnfield, MA |
Aug 07, 2024 Q2 2024 |
14
shares
|
$24
0.0% of portfolio
|
Q4 2023
New holding
|
|
Bfsg, LLC
|
Jul 29, 2024 Q2 2024 |
5
shares
|
$8
0.0% of portfolio
|
Q2 2024
Reduced 28.57%
|
|
Morgan Stanley
New York, NY |
Aug 14, 2024 Q2 2024 |
3
shares
|
$5
0.0% of portfolio
|
Q1 2024
Reduced 25.0%
|
|
New Edge Advisors, LLC
New Orleans, LA |
Aug 15, 2024 Q2 2024 |
2
shares
|
$3
0.0% of portfolio
|
Q2 2024
Reduced 33.33%
|
|
Cwm, LLC
|
Jul 09, 2024 Q2 2024 |
1
shares
|
$1
0.0% of portfolio
|
Q2 2024
Reduced 99.9%
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Jul 23, 2024 Q2 2024 |
0
shares
|
$0
0.0% of portfolio
|
Q2 2024
New holding
|